ArticleMedical science monitor : international medical journal of experimental and clinical research2024
Retracted: MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2).
Na Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.